Memory, Learning and Cognition

Cognition is the term used to define the process of thoughts, including memory, awareness, reasoning and perception. Cognitive enhancement describes the improvement of the information processing systems of the mind and the extension of its main capacities, which can be undertaken simply by learning, especially during early development.

Memory, Learning and Cognition Products Targets

Products for Memory, Learning and Cognition - Page 8

Cat.No. Product Name Information/Activity
BCC6478 UF 010 UF010 is a potent and selective HDAC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μM and 1.5 μM for HDACs 3, 2, 1 and 8, respectively.
BCC2156 Valproic acid sodium salt (Sodium valproate) Valproic acid sodium salt (Sodium Valproate) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium salt activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches.
BCC2306 Anagrelide HCl Anagrelide hydrochloride (BL4162A) is a drug used for the treatment of essential thrombocytosis.
BCC7940 BC 11-38 686770-80-9
BCN5807 Caffeine 58-08-2
BCC6173 Carbazeran citrate 153473-94-0
BCC7814 CDP 840 hydrochloride Potent and selective PDE4 inhibitor
BCC7338 CGH 2466 dihydrochloride Anti-inflammatory agent. Inhibitor of PDE4 and p38 MAPK, also adenosine receptor antagonist
BCC6843 Cilostamide Cilostamide is a selective and potent PDE3 inhibitor, with IC50s of 27 nM and 50 nM for PDE3A and PDE3B, respectively, and has antithrombotic and anti-intimal hyperplastic activity.
BCC2291 Cilostazol Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM.